来源： 类型：
chinadaily.com.cn |2020-12-31 China announced it has granted conditionalmarket approval for its first COVID-19 vaccine during a Thursday newsconference.
The vaccine, developed by State-owned Sinopharm, was approved by China'stop drug regulator on Wednesday night, said Chen Shifei, deputy head of theNational Medical Products Administration.
The vaccine is generally safe and has a79.34 percent efficacy rate according to clinical results released by thecompany on Wednesday. Strict supervision will continue to be carried out overthe vaccine after its approval to ensure its safety and quality, Chen said.
A total of 14 COVID-19 vaccinesdeveloped by China are now under clinical trials, including five under phase-3trials.
Before the official approval of thevaccine, the vaccine and several other COVID-19 vaccines in phase-3 clinicaltrials have already been put into emergency use in China over the past fewmonths. Millions of doses have been used for priority groups such as frontlinemedical workers and people going overseas to work, and the safety and efficacyof the vaccines have been proved, said Zeng Yixin, vice-minister in charge ofthe National Health Commission.
